Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines

Chest

Volumn 141, Issue 2 SUPPL., 2012, Pages e227S-e277S

  Gould, Michael K ^a   Garcia, David A ^b   Wren, Sherry M ^c   Karanicolas, Paul J ^d   Arcelus, Juan I ^e   Heit, John A ^f   Samama, Charles M ^g  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF GRANADA   (Spain)

^f MAYO CLINIC   (United States)

^g HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BEMIPARIN; CERTOPARIN; CLOPIDOGREL; DALTEPARIN; DIHYDROERGOTAMINE; DIPYRIDAMOLE; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PARNAPARIN; PLACEBO; REVIPARIN; TINZAPARIN; WARFARIN;

ABDOMINAL SURGERY; BARIATRIC SURGERY; BLEEDING; COMPRESSION GARMENT; CRANIOTOMY; DEEP VEIN THROMBOSIS; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG MEGADOSE; ECONOMIC EVALUATION; ELECTROSTIMULATION THERAPY; EVIDENCE BASED PRACTICE; GASTROINTESTINAL SURGERY; GENERAL SURGERY; GYNECOLOGIC SURGERY; HEART SURGERY; HEMATOMA; HIGH RISK PATIENT; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTRAOPERATIVE BLEEDING; LOW DRUG DOSE; LUNG EMBOLISM; MOBILIZATION; MORNING DOSAGE; MORTALITY; MOVEMENT THERAPY; PELVIS SURGERY; PLASTIC SURGERY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REOPERATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SPINAL CORD INJURY; SPINE SURGERY; SURGICAL PATIENT; THORAX SURGERY; THROMBOSIS PREVENTION; UROLOGIC SURGERY; VASCULAR SURGERY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; WOUND HEMATOMA;

EID: 84856778149     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2297     Document Type: Article

References (199)

1. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14):1711-1717. (Pubitemid 36898960)
2. Cucherat M. Trial Results Center(TRC). TRC Web site. http:// www.trialresultscenter.org. Accessed April 13, 2011.
3. Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of anti thrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(suppl):53S-70S.
4. Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212(1):105-112.
5. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-926. (Pubitemid 351632017)
6. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ; GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336(7651):995-998. (Pubitemid 351656090)
7. Guyatt GH, Oxman AD, Kunz R, et al; GRADE Working Group. Going from evidence to recommendations. BMJ. 2008;336(7652):1049-1051. (Pubitemid 351692246)
8. International Multicentre Trial. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet. 1975;2(7924):45-51.
9. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318(18):1162-1173.
10. Collen JF, Jackson JL, Shorr AF, Moores LK. Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest. 2008;134(2):237-249.
11. Pezzuoli G, Neri Serneri GG, Settembrini P, et al; STEP-Study Group. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo(STEP). Int Surg. 1989;74(4):205-210. (Pubitemid 20053077)
12. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000; 160(15):2327-2332.
13. Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88(7):913-930. (Pubitemid 34015572)
14. Geerts WH, Jay RM, Code KI, et al. A comparison of lowdose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335(10):701-707. (Pubitemid 26287356)
15. Akl EA, Terrenato I, Barba M, Sperati F, Muti P, Schünemann HJ. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Thromb Haemost. 2008;100(6):1176-1180.
16. Bottaro FJ, Elizondo MC, Doti C, et al. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Thromb Haemost. 2008; 99(6):1104-1111. (Pubitemid 351810493)
17. Rasmussen MS, Jørgensen LN, Wille-Jørgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;(1):CD004318.
18. Kakkar VV, Balibrea JL, Martínez-González J, Prandoni P; CANBESURE Study Group. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost. 2010; 8(6):1223-1229.
19. Turpie AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE; Apollo Investigators. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007;5(9):1854-1861. (Pubitemid 47288942)
20. Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M; PEGASUS investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg. 2005;92(10):1212-1220. (Pubitemid 41475229)
21. Pulmonary Embolism Prevention(PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention(PEP) trial. Lancet. 2000;355(9212):1295-1302.
22. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308(6923): 235-246.
23. Vanek VW. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thighhigh to knee-high sleeves. Am Surg. 1998;64(11):1050-1058. (Pubitemid 28484086)
24. Roderick P, Ferris G, Wilson K, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess. 2005;9(49):1-78.
25. Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost. 2005;94(6):1181-1185. (Pubitemid 41819613)
26. CLOTS Trials Collaboration; Dennis M, Sandercock PA, Reid J, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373(9679):1958-1965.
27. Sachdeva A, Dalton M, Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010;(7):CD001484.
28. Eppsteiner RW, Shin JJ, Johnson J, van Dam RM. Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis. World J Surg. 2010;34(1):10-19.
29. CLOTS(Clots in Legs Ors Tockings after Stroke) Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med. 2010;153(9):553-562.
30. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma. 2003;54(6):1116-1124.
31. Cornwell EE III, Chang D, Velmahos G, et al. Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis. Am Surg. 2002; 68(5):470-473. (Pubitemid 44897089)
32. National Collaborating Centre for Acute Care. Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis And Pulmonary Embolism) in Patients Admitted to Hospital. London, England: NICE; 2010.
33. Sweetland S, Green J, Liu B, et al; Million Women Study Collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583.
34. Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost. 2009; 102(5):951-957.
35. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(suppl):e278S-e325S.
36. Wille-Jørgensen P. Prophylaxis of postoperative thromboembolism with a combination of heparin and graduated compression stockings. Int Angiol. 1996;15(suppl 1):15-20. (Pubitemid 27101870)
37. Bergqvist D, Lindblad B. The thromboprophylactic effect of graded elastic compression stockings in combination with dextran 70. Arch Surg. 1984;119(11):1329-1331. (Pubitemid 15182212)
38. Wille-Jørgensen P, Hauch O, Dimo B, Christensen SW, Jensen R, Hansen B. Prophylaxis of deep venous thrombosis after acute abdominal operation. Surg Gynecol Obstet. 1991; 172(1):44-48.
39. Törngren S. Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis. Br J Surg. 1980;67(7):482-484. (Pubitemid 10080139)
40. Wille-Jørgensen P, Thorup J, Fischer A, Holst-Christensen J, Flamsholt R. Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: a randomized trial. Br J Surg. 1985;72(7):579-581. (Pubitemid 15065020)
41. Rasmussen A, Hansen PT, Lindholt J, et al. Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or both. J Med. 1988;19(3-4):193-201.
42. Ohlund C, Fransson SG, Starck SA. Calf compression for prevention of thromboembolism following hip surgery. Acta Orthop Scand. 1983;54(6):896-899. (Pubitemid 14210694)
43. Kalodiki EP, Hoppensteadt DA, Nicolaides AN, et al. Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement. A randomised controlled trial. Int Angiol. 1996;15(2):162-168.
44. Barnes RW, Brand RA, Clarke W, Hartley N, Hoak JC. Efficacy of graded-compression antiembolism stockings in patients undergoing total hip arthroplasty. Clin Orthop Relat Res. 1978;(132):61-67. (Pubitemid 8353519)
45. Fredin H, Bergqvist D, Cederholm C, Lindblad B, Nyman U. Thromboprophylaxis in hip arthroplasty. Dextran with graded compression or preoperative dextran compared in 150 patients. Acta Orthop Scand. 1989;60(6):678-681. (Pubitemid 20063231)
46. Smith RC, Elton RA, Orr JD, et al. Dextran and intermittent pneumatic compression in prevention of postoperative deep vein thrombosis: multiunit trial. BMJ. 1978;1(6118): 952-954. (Pubitemid 8316495)
47. Eisele R, Kinzl L, Koelsch T. Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis . J Bone Joint Surg Am. 2007;89(5):1050-1056. (Pubitemid 46724596)
48. Lieberman JR, Huo MM, Hanway J, Salvati EA, Sculco TP, Sharrock NE. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia . J Bone Joint Surg Am. 1994;76(3):341-348. (Pubitemid 24138927)
49. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br. 2004;86(6):809-812. (Pubitemid 39173465)
50. Siragusa S, Vicentini L, Carbone S, Barone M, Beltrametti C, Piovella F. Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post-operative deep vein thrombosis in hip surgery: a randomized clinical trial [abstract]. Br J Haematol. 1994; 87(Suppl s1):186.
51. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338(7):409-415. (Pubitemid 28135667)
52. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416-422.
53. Birkmeyer NJ, Share D, Baser O, et al; Michigan Bariatric Surgery Collaborative. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg. 2010;252(2):313-318.
54. Rajasekhar A, Lottenberg R, Lottenberg L, Liu H, Ang D. Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the metaanalysis of observational studies in epidemiology(MOOSE) guidelines. J Thromb Thrombolysis. 2011;32(1):40-46.
55. Girard TD, Philbrick JT, Fritz Angle J, Becker DM. Prophylactic vena cava filters for trauma patients: a systematic review of the literature. Thromb Res. 2003;112(5-6):261-267.
56. White RH, Goulet JA, Bray TJ, Daschbach MM, McGahan JP, Hartling RP. Deep-vein thrombosis after fracture of the pelvis: assessment with serial duplex-ultrasound screening. J Bone Joint Surg Am. 1990;72(4):495-500. (Pubitemid 20150417)
57. Burns GA, Cohn SM, Frumento RJ, Degutis LC, Hammers L. Prospective ultrasound evaluation of venous thrombosis in high-risk trauma patients. J Trauma. 1993;35(3):405-408. (Pubitemid 23292491)
58. Napolitano LM, Garlapati VS, Heard SO, et al. Asymptom atic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma. 1995; 39(4):651-659.
59. Meythaler JM, DeVivo MJ, Hayne JB. Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation. Arch Phys Med Rehabil. 1996;77(1):1-5. (Pubitemid 26017482)
60. Satiani B, Falcone R, Shook L, Price J. Screening for major deep vein thrombosis in seriously injured patients: a prospective study. Ann Vasc Surg. 1997;11(6):626-629. (Pubitemid 27479364)
61. Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002;52(3):453-462. (Pubitemid 34230076)
62. Oster G, Tuden RL, Colditz GA. Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis. Am J Med. 1987;82(5):889-899.
63. Etchells E, McLeod RS, Geerts W, Barton P, Detsky AS. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery. Arch Intern Med. 1999;159(11):1221-1228. (Pubitemid 29269862)
64. Szucs TD, Schramm W. The cost-effectiveness of low-molecular- weight heparin vs unfractionated heparin in general and orthopaedic surgery: an analysis for the German healthcare system. Pharmacol Res. 1999;40(1):83-89. (Pubitemid 29317429)
65. Maxwell GL, Myers ER, Clarke-Pearson DL. Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. Obstet Gynecol. 2000;95(2):206-214. (Pubitemid 30045641)
66. Heerey A, Suri S. Cost effectiveness of dalteparin for preventing venous thromboembolism in abdominal surgery. Pharmacoeconomics. 2005;23(9):927-944. (Pubitemid 41317426)
67. Dainty L, Maxwell GL, Clarke-Pearson DL, Myers ER. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. Gynecol Oncol. 2004;93(2):366-373. (Pubitemid 38507603)
68. Farias-Eisner R, Horblyuk R, Franklin M, Lunacsek OE, Happe LE. Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery. Curr Med Res Opin. 2009;25(5):1081-1087.
69. Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature. Surg Laparosc Endosc. 1997; 7(4):324-331.
70. Wazz G, Branicki F, Taji H, Chishty I. Influence of pneumoperitoneum on the deep venous system during laparoscopy. JSLS. 2000;4(4):291-295.
71. Catheline JM, Capelluto E, Gaillard JL, Turner R, Champault G. Thromboembolism prophylaxis and incidence of thromboembolic complications after laparoscopic surgery. Int J Surg Investig. 2000;2(1):41-47.
72. Blake AM, Toker SI, Dunn E. Deep venous thrombosis prophylaxis is not indicated for laparosocopic cholecystectomy. JSLS. 2001;5(3):215-219.
73. Bergqvist D, Lowe G. Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts. Arch Intern Med. 2002;162(19):2173-2176. (Pubitemid 35231584)
74. Enoch S, Woon E, Blair SD. Thromboprophylaxis can be omitted in selected patients undergoing varicose vein surgery and hernia repair. Br J Surg. 2003;90(7):818-820. (Pubitemid 36886382)
75. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446-455. (Pubitemid 37138770)
76. Andtbacka RH, Babiera G, Singletary SE, et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg. 2006;243(1):96-101. (Pubitemid 43054060)
77. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45(2):335-342.
78. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243(1):89-95. (Pubitemid 43054059)
79. Alcalay A, Wun T, Khatri V, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006;24(7):1112-1118. (Pubitemid 46638808)
80. Clarke-Pearson DL, Dodge RK, Synan I, McClelland RC, Maxwell GL. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet Gynecol. 2003;101(1):157-163. (Pubitemid 36057102)
81. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010; 251(2):344-350.
82. Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1211-1221. (Pubitemid 46819093)
83. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51(2-3):70-78. (Pubitemid 40719347)
84. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991;17(suppl 3):304-312.
85. Jeong O, Ryu SY, Park YK, Kim YJ. The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery. Ann Surg Oncol. 2010;17(9):2363-2369.
86. Koukoutsis I, Bellagamba R, Morris-Stiff G, et al. Haemorrhage following pancreaticoduodenectomy: risk factors and the importance of sentinel bleed. Dig Surg. 2006;23(4):224-228. (Pubitemid 44651421)
87. Sima CS, Jarnagin WR, Fong Y, et al. Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg. 2009;250(6):914-921.
88. Kakkar VV, Cohen AT, Edmonson RA, et al; The Thromboprophylaxis Collaborative Group. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet. 1993; 341(8840):259-265. (Pubitemid 23038022)
89. Rocha AT, de Vasconcellos AG, da Luz Neto ER, Araújo DM, Alves ES, Lopes AA. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16(12):1645-1655.
90. Morawski W, Sanak M, Cisowski M, et al. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg. 2005;130(3):791-796. (Pubitemid 41265721)
91. Kang W, Theman TE, Reed JF III, Stoltzfus J, Weger N. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery. J Surg Educ. 2007;64(2): 88-92. (Pubitemid 46488891)
92. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004;78(2):527-534. (Pubitemid 38980767)
93. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg. 1996;111(5):1037-1046. (Pubitemid 26146058)
94. Detterbeck FC. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia, PA: WB Saunders; 2001.
95. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg. 2006;141(8):790-797. (Pubitemid 44268523)
96. Cohen AT, Wagner MB, Mohamed MS. Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis . Am J Surg. 1997;174(1):1-5. (Pubitemid 27343849)
97. American Society for Metabolic and Bariatric Surgery. Rationale for the surgical treatment of morbid obesity. November 2005. ASMBS Web site. http://asmbs.org/rationale-for- surgical-treatment/. Accessed August 5, 2011.
98. Carmody BJ, Sugerman HJ, Kellum JM, et al. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution's 24-year experience. J Am Coll Surg. 2006;203(6):831-837. (Pubitemid 44751566)
99. Gargiulo NJ III, Veith FJ, Lipsitz EC, et al. The incidence of pulmonary embolism in open versus laparoscopic gastric bypass. Ann Vasc Surg. 2007;21(5):556-559. (Pubitemid 47333062)
100. Piano G, Ketteler ER, Prachand V, et al. Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients. J Vasc Surg. 2007;45(4):784-788. (Pubitemid 46483947)
101. Raftopoulos I, Martindale C, Cronin A, Steinberg J. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc. 2008;22(11):2384-2391.
102. Inabnet WB III, Belle SH, Bessler M, et al. Comparison of 30-day outcomes after non-LapBand primary and revisional bariatric surgical procedures from the Longitudinal Assessment of Bariatric Surgery study. Surg Obes Relat Dis. 2010;6(1):22-30.
103. Caruana JA, McCabe MN, Smith AD, Stawiasz KA, Kabakov E, Kabakov JM. Roux en Y gastric bypass by single-incision mini-laparotomy: outcomes in 3,300 consecutive patients. Obes Surg. 2011;21(7):820-824.
104. Stroh C, Birk D, Flade-Kuthe R, et al; Study Group Obesity Surgery. Evidence of thromboembolism prophylaxis in bariatric surgery-results of a quality assurance trial in bariatric surgery in Germany from 2005 to 2007 and review of the literature. Obes Surg. 2009;19(7):928-936.
105. Poulose BK, Griffin MR, Zhu Y, et al. National analysis of adverse patient safety for events in bariatric surgery. Am Surg. 2005;71(5):406-413. (Pubitemid 43073460)
106. Gonzalez QH, Tishler DS, Plata-Munoz JJ, et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2004;18(7): 1082-1084 (Pubitemid 38918021)
107. Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003; 13(6):819-825. (Pubitemid 38010697)
108. Flum DR, Belle SH, King WC, et al; Longitudinal Assessment of Bariatric Surgery(LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445-454.
109. Belch JJ, Lowe GD, Pollock JG, Forbes CD, Prentice CR. Low dose heparin in the prevention of deep-vein thrombosis after aortic bifurcation graft surgery. Thromb Haemost. 1980;42(5):1429-1433. (Pubitemid 10143917)
110. Harjola P, Meurala H, Frick MH. Prevention of deep venous thrombosis and thrombo-embolism by dipyridamole and acetylsalicylic acid after reconstructive arterial surgery. J Cardiovasc Surg(Torino). 1980;21(4):451-454. (Pubitemid 11200755)
111. Spebar MJ, Collins GJ Jr, Rich NM, Kang IY, Clagett GP, Salander JM. Perioperative heparin prophylaxis of deep venous thrombosis in patients with peripheral vascular disease. Am J Surg. 1981;142(6):649-650.
112. Urbanyi B. Prophylaxis against thromboembolism in vascular surgery: a randomised clinical trial. Vasc Surg. 1982; 16(4):253-259. (Pubitemid 12041314)
113. Speziale F, Verardi S, Taurino M, et al. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery. Pharmatherapeutica. 1988; 5(4):261-268.
114. Farkas JC, Chapuis C, Combe S, et al. A randomised controlled trial of a low-molecular-weight heparin(enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery. Eur J Vasc Surg. 1993;7(5):554-560. (Pubitemid 23266307)
115. Killewich LA, Aswad MA, Sandager GP, Lilly MP, Flinn WR. A randomized, prospective trial of deep venous thrombosis prophylaxis in aortic surgery. Arch Surg. 1997;132(5):499-504. (Pubitemid 27215090)
116. Lastória S, Rollo HA, Yoshida WB, Giannini M, Moura R, Maffei FH. Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin. Acta Cir Bras. 2006;21(3):184-186. (Pubitemid 43845841)
117. de Maistre E, Terriat B, Lesne-Padieu AS, Abello N, Bouchot O, Steinmetz EF. High incidence of venous thrombosis after surgery for abdominal aortic aneurysm. J Vasc Surg. 2009;49(3):596-601.
118. Yeager RA, Moneta GL, Edwards JM, Taylor LM Jr, McConnell DB, Porter JM. Deep vein thrombosis associated with lower extremity amputation. J Vasc Surg. 1995; 22(5):612-615.
119. Olin JW, Graor RA, O'Hara P, Young JR. The incidence of deep venous thrombosis in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg. 1993;18(6):1037-1041. (Pubitemid 24020798)
120. Tawfick WA, Tawfik S, Hynes N, Mahendran B, Sultan S. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII. Vascular. 2006; 14(1):32-37.
121. Hatef DA, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008;122(1):269-279.
122. Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May JW Jr, Orgill DP. Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;121(4):1101-1107. (Pubitemid 351653204)
123. Kim EK, Eom JS, Ahn SH, Son BH, Lee TJ. The efficacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM flap. Plast Reconstr Surg. 2009; 123(1):9-12.
124. Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. Am Heart J. 1996;132(2 pt 1):314-318. (Pubitemid 26292396)
125. Ramos R, Salem BI, De Pawlikowski MP, Coordes C, Eisenberg S, Leidenfrost R. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest. 1996;109(1):82-85. (Pubitemid 26017598)
126. Hannan EL, Racz MJ, Walford G, et al. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA. 2003;290(6):773-780. (Pubitemid 37432954)
127. DeLaria GA, Hunter JA. Deep venous thrombosis. Implications after open heart surgery. Chest. 1991;99(2):284-288.
128. Gillinov AM, Davis EA, Alberg AJ, Rykiel M, Gardner TJ, Cameron DE. Pulmonary embolism in the cardiac surgical patient. Ann Thorac Surg. 1992;53(6):988-991.
129. Josa M, SiouffiSY, Silverman AB, Barsamian EM, Khuri SF, Sharma GV. Pulmonary embolism after cardiac surgery. J Am Coll Cardiol. 1993;21(4):990-996. (Pubitemid 23106166)
130. Ambrosetti M, Salerno M, Zambelli M, Mastropasqua F, Tramarin R, Pedretti RFE. Deep vein thrombosis among patients entering cardiac rehabilitation after coronary artery bypass surgery. Chest. 2004;125(1):191-196. (Pubitemid 38114583)
131. Egawa N, Hiromatsu S, Shintani Y, Kanaya K, Fukunaga S, Aoyagi S. Prevention of venous thromboembolism in thoracic and cardiovascular surgery. Asian Cardiovasc Thorac Ann. 2009;17(5):505-509.
132. Cartier R, Robitaille D. Thrombotic complications in beating heart operations. J Thorac Cardiovasc Surg. 2001; 121(5):920-922.
133. Reynolds MW, Clark J, Crean S, Samudrala S. Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature. Patient Saf Surg. 2008;2 :5.
134. Yellin A, Refaely Y, Paley M, Simansky D. Major bleeding complicating deep sternal infection after cardiac surgery. J Thorac Cardiovasc Surg. 2003;125(3):554-558. (Pubitemid 36373901)
135. Potger KC, McMillan D, Southwell J, Connolly T, Smith KK, Ambrose M. Transfusion and bleeding in coronary artery bypass grafting: an on-pump versus off-pump comparison. J Extra Corpor Technol. 2007;39(1):24-30. (Pubitemid 351506732)
136. Cade JF, Clegg EA, Westlake GW. Prophylaxis of venous thrombosis after major thoracic surgery. Aust N Z J Surg. 1983;53(4):301-304. (Pubitemid 14200287)
137. Azorin JF, Regnard JF, Dahan M, Pansart M. Efficacy and tolerability of fraxiparine in the prevention of thromboembolic complications in oncologic thoracic surgery [in French]. Ann Cardiol Angeiol(Paris). 1997;46(5-6):341-347.
138. Kalweit G, Huwer H, Volkmer I, Petzold T, Gams E. Pulmonary embolism: a frequent cause of acute fatality after lung resection. Eur J Cardiothorac Surg. 1996;10(4): 242-247. (Pubitemid 126690724)
139. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Intermittent pneumatic compression is effective in preventing symptomatic pulmonary embolism
140. Mason DP, Quader MA, Blackstone EH, et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg. 2006;131(3):711-718.
141. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128(1):138-146. (Pubitemid 38881208)
142. Ziomek S, Read RC, Tobler HG, et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg. 1993; 56(2):223-227. (Pubitemid 23245127)
143. Ljungström KG. Deep-vein thrombosis after major noncardiovascular thoracic surgery. Scand J Thorac Cardiovasc Surg. 1985;19(2):161-164.
144. Daddi G, Milillo G, Lupattelli L, et al; Pulmonary Embolism in Thoracic Surgery Study Group. Postoperative pulmonary embolism detected with multislice computed tomography in lung surgery for cancer. J Thorac Cardiovasc Surg. 2006;132(1):197-198.
145. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg. 2006;81(2):421-426. (Pubitemid 43120529)
146. Skillman JJ, Collins RE, Coe NP, et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery. 1978;83(3):354-358. (Pubitemid 8286777)
147. Turpie AG, Hirsh J, Gent M, Julian D, Johnson J. Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med. 1989;149(3):679-681. (Pubitemid 19092867)
148. Ruff RL, Posner JB. Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol. 1983;13(3):334-336.
149. Simanek R, Vormittag R, Hassler M, et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro-oncol. 2007;9(2):89-95. (Pubitemid 46580310)
150. Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg. 2011;114(1):40-46.
151. Chan AT, Atiemo A, Diran LK, et al. Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis. 1999;8(2):139-142. (Pubitemid 29410839)
152. Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney- Wilensky E, Stein SC. Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery. 2005;56(6):1286-1292, discussion 1292-1294.
153. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89(3): 640-646. (Pubitemid 30640111)
154. Gruber UF, Rem J, Meisner C, Gratzl O. Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations. Eur Arch Psychiatry Neurol Sci. 1984;234(3):157-161. (Pubitemid 14020495)
155. Voth D, Schwarz M, Hahn K, Dei-Anang K, al Butmeh S, Wolf H. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Neurosurg Rev. 1992;15(4): 289-294. (Pubitemid 23018621)
156. Rokito SE, Schwartz MC, Neuwirth MG. Deep vein thrombosis after major reconstructive spinal surgery. Spine(Phila Pa 1976). 1996;21(7):853-859.
157. Nelson LD Jr, Montgomery SP, Dameron TB Jr, Nelson RB. Deep vein thrombosis in lumbar spinal fusion: a prospective study of antiembolic and pneumatic compression stockings. J South Orthop Assoc. 1996;5(3):181-184.
158. Wood KB, Kos PB, Abnet JK, Ista C. Prevention of deepvein thrombosis after major spinal surgery: a comparison study of external devices. J Spinal Disord. 1997;10(3):209-214. (Pubitemid 27280277)
159. Catre MG. Anticoagulation in spinal surgery. A critical review of the literature. Can J Surg. 1997;40(6):413-419.
160. Cheng JS, Arnold PM, Anderson PA, Fischer D, Dettori JR. Anticoagulation risk in spine surgery. Spine(Phila Pa 1976). 2010;35(Suppl 9):S117-S124.
161. Sansone JM, del Rio AM, Anderson PA. The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J Bone Joint Surg Am. 2010; 92(2):304-313.
162. Gerlach R, Raabe A, Beck J, Woszczyk A, Seifert V. Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J. 2004; 13(1):9-13. (Pubitemid 38269943)
163. Oda T, Fuji T, Kato Y, Fujita S, Kanemitsu N. Deep venous thrombosis after posterior spinal surgery. Spine(Phila Pa 1976). 2000;25(22):2962-2967.
164. Epstein NE. Intermittent pneumatic compression stocking prophylaxis against deep venous thrombosis in anterior cervical spinal surgery: a prospective efficacy study in 200 patients and literature review. Spine(Phila Pa 1976). 2005; 30(22):2538-2543.
165. Wen DY, Hall WA. Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol. 1998;50(6):521-525. (Pubitemid 29031331)
166. Frisbie JH, Sasahara AA. Low dose heparin prophylaxis for deep venous thrombosis in acute spinal cord injury patients: a controlled study. Paraplegia. 1981;19(6):343-346. (Pubitemid 12249612)
167. Green D, Rossi EC, Yao JS, Flinn WR, Spies SM. Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole. Paraplegia. 1982;20(4):227-234. (Pubitemid 12050092)
168. Green D, Lee MY, Ito VY, et al. Fixed-vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury. JAMA. 1988;260(9):1255- 1258.
169. Merli GJ, Herbison GJ, Ditunno JF, et al. Deep vein thrombosis: prophylaxis in acute spinal cord injured patients. Arch Phys Med Rehabil. 1988;69(9):661-664.
170. Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med. 1990;113(8):571-574. (Pubitemid 20346184)
171. Lohmann U, Gläser E, Braun BE, Bötel U. [Prevention of thromboembolism in spinal fractures with spinal cord injuries. Standard heparin versus low-molecular-weight heparin in acute paraplegia]. Zentralbl Chir. 2001;126(5):385-390.
172. Chiou-Tan FY, Garza H, Chan KT, et al. Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injury. Am J Phys Med Rehabil. 2003;82(9):678-685. (Pubitemid 37022515)
173. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma. 1995;9(1):1-7.
174. Fuchs S, Heyse T, Rudofsky G, Gosheger G, Chylarecki C. Continuous passive motion in the prevention of deep-vein thrombosis: a randomised comparison in trauma patients. J Bone Joint Surg Br. 2005;87(8):1117-1122. (Pubitemid 41131562)
175. Haentjens P; The Belgian Fraxiparine Study Group. Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin(nadroparin calcium). Injury. 1996;27(6):385-390.
176. Stannard JP, Lopez-Ben RR, Volgas DA, et al. Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. J Bone Joint Surg Am. 2006;88(2):261-266. (Pubitemid 43185125)
177. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24):1601-1606. (Pubitemid 24372057)
178. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240(3):490-498. (Pubitemid 39121343)
179. Hemmila MR, Jakubus JL, Maggio PM, et al. Real money: complications and hospital costs in trauma patients. Surgery. 2008;144(2):307-316. (Pubitemid 352010325)
180. Chen D, Apple DF Jr, Hudson LM, Bode R. Medical complications during acute rehabilitation following spinal cord injury - current experience of the Model Systems. Arch Phys Med Rehabil. 1999;80(11):1397-1401. (Pubitemid 29526636)
181. Jones T, Ugalde V, Franks P, Zhou H, White RH. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil. 2005;86(12):2240-2247. (Pubitemid 41774596)
182. Platzer P, Thalhammer G, Jaindl M, et al. Thromboembolic complications after spinal surgery in trauma patients. Acta Orthop. 2006;77(5):755-760. (Pubitemid 44521915)
183. Kim KS, Brophy GM. Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care. 2009;11(1):28-33.
184. Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW III. Traumatic brain injury is asso ciated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66(5):1436-1440.
185. Nathens AB, McMurray MK, Cuschieri J, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62(3):557-563.
186. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P. Prevention of venous thromboembolism after injury: an evidence-based report - part II: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma. 2000;49(1):140-144.
187. Green D, Hartwig D, Chen D, Soltysik RC, Yarnold PR. Spinal cord injury risk assessment for thromboembolism (SPIRATE Study). Am J Phys Med Rehabil. 2003;82(12): 950-956. (Pubitemid 37486309)
188. Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008;65(5):1021-1026.
189. Knudson MM, Morabito D, Paiement GD, Shackleford S. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma. 1996;41(3): 446-459. (Pubitemid 26318072)
190. Elliott CG, Dudney TM, Egger M, et al. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma. 1999;47(1):25-32. (Pubitemid 29361587)
191. Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM; Miami Deep Vein Thrombosis Study Group. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg. 2003;90(11):1338-1344. (Pubitemid 37421666)
192. Cuschieri J, Freeman B, O'Keefe G, et al; Inflammation and the Host Response to Injury Collaborative Research Program. Inflammation and the host response to injury a large-scale collaborative project: patient-oriented research core standard operating procedure for clinical care X. Guidelines for venous thromboembolism prophylaxis in the trauma patient [published correction appears in J Trauma. 2009 Mar;66(3):965]. J Trauma. 2008;65(4):944-950.
193. Ploumis A, Ponnappan RK, Bessey JT, Patel R, Vaccaro AR. Thromboprophylaxis in spinal trauma surgery: consensus among spine trauma surgeons. Spine J. 2009;9(7): 530-536.
194. Bergqvist D, Agnelli G, Cohen AT, et al; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975-980.
195. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis:2500 versus 5000 XaI units in 2070 patients. Br J Surg. 1995;82(4):496-501.
196. Rosencher N, Zufferey P, Samama CM. Definition of major bleeding in surgery: an anesthesiologist's point of view: a rebuttal. J Thromb Haemost. 2010;8(6):1442-1443.
197. Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202-204.
198. Committee for Medicinal Products for Human Use (CHMP). Guideline on Clinical Investigation of Medicinal Products for Prophylaxis of High Intra-and Post-Operative Venous Thromboembolic Risk. London, England: European Medicines Agency;2007.
199. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg. 2005;241(3):397-415. (Pubitemid 40299716)